{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:52:59Z","timestamp":1791262379126,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200424"],"award-info":[{"award-number":["82200424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2022SF-078"],"award-info":[{"award-number":["2022SF-078"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.atherosclerosis.2026.121885","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:58:26Z","timestamp":1787587106000},"page":"121885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden"],"prefix":"10.1016","volume":"421","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-3523","authenticated-orcid":false,"given":"Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-5540","authenticated-orcid":false,"given":"Fuxian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-8852","authenticated-orcid":false,"given":"Dengfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.atherosclerosis.2026.121885_bib1","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121885_bib3","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1161\/CIR.0000000000000709","article-title":"Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American heart association","volume":"140","author":"Skulas-Ray","year":"2019","journal-title":"Circulation"},{"issue":"7855","key":"10.1016\/j.atherosclerosis.2026.121885_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121885_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/apha.70062","article-title":"Specialized pro-resolving mediators as emerging players in cardioprotection: from inflammation resolution to therapeutic potential","volume":"241","author":"De Bartolo","year":"2025","journal-title":"Acta Physiol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121885_bib6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts","volume":"131","author":"W\u00fcrtz","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121885_bib7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention","volume":"19","author":"Araki","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.121885_bib8","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.121885_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.121885_bib10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.121885_bib11","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121885_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12967-017-1321-6","article-title":"GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk","volume":"15","author":"Connelly","year":"2017","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121885_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083707","article-title":"The advanced glycation end-products (AGE)-Receptor for AGE System (RAGE): an inflammatory pathway linking obesity and cardiovascular diseases","volume":"26","author":"Vianello","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.121885_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14134606","article-title":"The role of NLRP3 inflammasome in type 2 diabetes mellitus and its macrovascular complications","volume":"14","author":"Karamitsos","year":"2025","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121885_bib16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41569-023-00984-x","article-title":"Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease","volume":"21","author":"Fredman","year":"2024","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41467-024-44868-1","article-title":"Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease","volume":"15","author":"Walker","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11883-025-01363-2","article-title":"N-3 Fatty acids (EPA and DHA) and cardiovascular health - updated review of mechanisms and clinical outcomes","volume":"27","author":"Djuricic","year":"2025","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121885_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121885_bib20","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s43587-021-00150-3","article-title":"Molecular damage in aging","volume":"1","author":"Gladyshev","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.atherosclerosis.2026.121885_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2022.06.1018","article-title":"Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: implications for primary prevention","volume":"353","author":"Alfaddagh","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.121885_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1538505","article-title":"The influence of FADS genetic variation and omega-3 fatty acid deficiency on cardiometabolic disease risk in a Mexican American population","volume":"12","author":"Blomquist","year":"2025","journal-title":"Front Nutr"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121885_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.123.065520","article-title":"Randomized trial for evaluation in secondary prevention efficacy of combination therapy-statin and eicosapentaenoic acid (RESPECT-EPA)","volume":"150","author":"Miyauchi","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12944-025-02676-6","article-title":"Global variations in omega-3 fatty acid status and omega-6:omega-3 ratios: insights from > 500,000 whole-blood dried blood spot samples","volume":"24","author":"Torrissen","year":"2025","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121885_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2026.100774","article-title":"Phenotypic age acceleration and omega-6\/omega-3 PUFA ratio in dynamic atrial fibrillation-heart failure transitions: a multistate analysis","volume":"30","author":"Zhang","year":"2026","journal-title":"J Nutr Health Aging"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121885_bib26","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","article-title":"Participation bias in the UK Biobank distorts genetic associations and downstream analyses","volume":"7","author":"Schoeler","year":"2023","journal-title":"Nat Hum Behav"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121885_bib27","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1161\/ATVBAHA.124.319570","article-title":"\"A Time to Tear Down and a Time to Mend\": the role of eicosanoids in atherosclerosis","volume":"44","author":"Sherratt","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.121885_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","article-title":"Mediation analysis: a practitioner's guide","volume":"37","author":"VanderWeele","year":"2016","journal-title":"Annu Rev Publ Health"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121885_bib29","article-title":"The effect of Omega-3 fatty acids on insulin resistance","volume":"13","author":"Sinha","year":"2023","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000451","article-title":"Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study","volume":"3","author":"Chen","year":"2024","journal-title":"BMJ Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib32","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/s41467-021-22370-2","article-title":"Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies","volume":"12","author":"Harris","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121885_bib33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of smoking cessation with subsequent risk of cardiovascular disease","volume":"322","author":"Duncan","year":"2019","journal-title":"JAMA"},{"issue":"10384","key":"10.1016\/j.atherosclerosis.2026.121885_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121885_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2024.04.060","article-title":"Lipidomic risk score to enhance cardiovascular risk stratification for primary prevention","volume":"84","author":"Wu","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121885_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12933-025-02581-3","article-title":"Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics","volume":"24","author":"Xie","year":"2025","journal-title":"Cardiovasc Diabetol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:17:44Z","timestamp":1791260264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026012517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"alternative-id":["S0021915026012517"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121885","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121885"}}